ASP7487 (OSI-906)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ASP7487 (OSI-906), covering 2018-09-13 to 2018-09-13. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma [Phase 1, Phase 2]